TTI acquires Ray-Q Ltd.

Since 2000 the company has been incorporated as a representative, consultant, and distributor of leading technologies and interconnect products of leading world class manufacturers for Israel, Turkey, Eastern and parts of Central Europe, and India. Gene Conahan, President TTI Europe and Asia, on the acquisition: “It’s not often a company has the opportunity to add such longevity and superior technical value to their service offering. I am very pleased to be bringing the wiring and harness assembly expertise of Ray-Q to the TTI teams in Europe and Asia – and to the benefit of our customers worldwide.” Ray-Q employs approximately 70 associates and counts among their customers virtually every major defense contractor.” Yigal Funt, Ray-Q Chief Executive Officer since 1976, states: “On behalf of our associates and customers, I can confidently say that we are most pleased to be joining such venerable organizations as TTI and Berkshire Hathaway. We look forward to their support in the globalization of our vision to be a prime supplier of electrical and FO interconnect products and solutions to high reliability system manufacturers. Becoming part of TTI will greatly enhance our added value activities in the support of the design and implementation of interconnect systems for our customers.” Mr. Funt will continue to lead the Ray-Q organization and business initiatives while reporting directly to Mr. Conahan. Paul Andrews, TTI Founder and Chief Executive Officer, comments: “While Ray-Q’s long track record of success speaks for itself, I am particularly gratified by the company’s mission - ‘To be a Supplier of Choice – always dealing ethically with our customers, our supplier partners and fellow employees’. These are the values that have been core to TTI’s success for over 40 years and ensure that this is an excellent cultural fit for both of our companies. My team and I welcome Ray-Q’s associates and customers to the TTI and Berkshire Hathaway family.” Completion of the transaction is subject to regulatory approvals in Israel.